1. Zolgensma is Novartis’ $2.1 million gene therapy for spinal muscular atrophy, an inherited muscle-wasting disease that is often fatal to patients before age 2. It is the world’s most expensive drug.
2. Piqray, which comes in a tablet form, is the first PI3K inhibitor for the treatment of breast cancer. It is approved for use in combination with endocrine therapy fulvestrant.
3. SurgicalAR is an augmented reality platform that enhances small, otherwise difficult to see details for surgeons performing various surgeries.
4. Nervio Migra is a wireless device that stimulates acute migraine relief. It attaches to a patient’s upper arm.
More articles on supply chain:
Blood shortage spurs rationing, threatens patient care in Southern hospitals
How 2 health systems are moving the needle on costs & outcomes with an optimized supply chain
FDA recalls 3 blood test analyzers
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.